<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">Human papillomavirus is associated with oral and genital cancers (
 <xref rid="bib19" ref-type="bibr">D'Souza and Addepalli, 2018</xref>; 
 <xref rid="bib62" ref-type="bibr">Shafabakhsh et al., 2019</xref>). Melatonin exerted a defensive impact on oral cancer and oral ulcer. The preventive and controlling role of melatonin on oral cancer caused due to HPV was attributed primarily to immunoenhancement by increasing T &amp; B lymphocyte activity, increasing monocyte activity, increasing natural killer cell activity, and increasing the secretion of cytokines (IL-6 and IL-2), which ultimately lead to oncostatic activity (
 <xref rid="bib19" ref-type="bibr">D'Souza and Addepalli, 2018</xref>). In addition, melatonin in combination with indoleamine 2,3-dioxygenase-1 inhibitor, administered as an immunometabolic adjuvant, improved the efficacy of immunotherapeutic treatment of HPV-associated tumors (
 <xref rid="bib49" ref-type="bibr">Moreno et al., 2018</xref>).
</p>
